Partnership for Safe Medicines

We educate the public about the dangers of counterfeit drugs.

[Partnership for Safe Medicines @SafeMedicines]

Read more news about counterfeit drugs here: https://t.co/pOq9SN4kIm

[Partnership for Safe Medicines @SafeMedicines]

Jenifer Cleveland reportedly collapsed 27 minutes into an IV infusion meant to take 24 hours at a med spa that allegedly lacked emergency equipment and trained staff. Her death led to the passage of Jenifer’s Law in Texas.

More: https://t.co/NIHzncAWMU.

#MedSpa #PublicHealth

[Partnership for Safe Medicines @SafeMedicines]

If you’re living with HIV and wondering about medication assistance, this tool was built for you. The ADAP Eligibility Calculator provides quick, educational guidance about possible eligibility. Learn more: https://t.co/b9NdIcgzpq

[Partnership for Safe Medicines @SafeMedicines]

Scammers in Malaysia and the UK are cloning trusted pharmacy brands online to push counterfeit products. Even after takedowns, fake listings keep returning. If the deal looks too good to be true, it probably is.

More: https://t.co/NIHzncAWMU.

#Pharmacy #PublicHealth

[Partnership for Safe Medicines @SafeMedicines]

“Peptide washing” helps normalize a dangerous trend: treating experimental, potentially dangerous, injectable compounds as casual wellness products. Scientific American discusses in a new podcast.

More: https://t.co/NIHzncAWMU.

#Wellness #Peptides

[Partnership for Safe Medicines @SafeMedicines]

More than 6.4 million doses of illicit pharmaceuticals were shut down, and thousands of websites selling fake medicine online were taken down during INTERPOL’s latest global operation targeting online pharmaceutical crime.

More: https://t.co/NIHzncAWMU.

#INTERPOL #PublicHealth

[Partnership for Safe Medicines @SafeMedicines]

A year-long investigation by CT AG Tong led to major changes at https://t.co/zU3syQvFnT, including stopping U.S. sales of questionable GLP-1 products and adding monitoring systems to catch listings before they go live.

More in our May 11 news roundup.

#WeightLoss #Connecticut

[Partnership for Safe Medicines @SafeMedicines]

An FDA warning letter to Intas Pharmaceuticals details major manufacturing and recordkeeping failures tied to potentially adulterated drugs and recalls linked to critical medications.

More: https://t.co/Je5VVmXIcA.

#FDA #PatientSafety #PublicHealth

[Partnership for Safe Medicines @SafeMedicines]

“Anecdotal” expiration dating? FDA says Lexia LLC lacked adequate testing and stability data needed to ensure drug safety, quality, and effectiveness. Patients deserve evidence-based standards, not assumptions.

More: https://t.co/Je5VVmXIcA.

#FDA #MedicineSafety #PublicHealth

[Partnership for Safe Medicines @SafeMedicines]

A new study found 1 in 5 consumers unknowingly bought counterfeit medicine, and 1 in 10 people who purchased drugs online reported being harmed. Fake medicines are increasingly spreading through online pharmacies and social media.

More: https://t.co/Je5VVmXIcA

#OnlinePharmacies

[Partnership for Safe Medicines @SafeMedicines]

The FDA is moving to limit large-scale compounding of some GLP-1s by a proposal to restrict them from the 503B bulks list. We support the move and believe approved medicines should come first.

More: https://t.co/Je5VVmXIcA.

#FDA #Compounding #GLP1

[Partnership for Safe Medicines @SafeMedicines]

A cancer patient in Mexico uncovered that his Keytruda treatment was counterfeit, a discovery that triggered investigations into fake cancer drugs circulating through parts of the country’s health system.

Read more: https://t.co/L7AxCDDuIN.

[Partnership for Safe Medicines @SafeMedicines]

A bill meant to strengthen med spa oversight, SB130, was postponed, despite proposals for provider accountability, adverse event reporting, and safer drug handling. As med spas expand, consistent regulation remains a critical gap.

Read more: https://t.co/fMPHkrejoS

#MedSpa

[Partnership for Safe Medicines @SafeMedicines]

The FDA has warned New Life Pharma after finding unapproved injectable weight-loss drugs, along with serious sterility and quality control failures, and obstruction during inspection.

Read more: https://t.co/fMPHkrejoS

#FDA #WeightLoss #PublicSafety

[Partnership for Safe Medicines @SafeMedicines]

An FDA warning letter highlights unsafe sterile compounding practices at Thrive Health Solutions, from improper cleanroom procedures to unapproved injectable drugs being sold without assurance of sterility.

Read more: https://t.co/fMPHkrejoS

#FDA #PublicHealth #Compounding

[Partnership for Safe Medicines @SafeMedicines]

If you’re living with HIV and wondering about medication assistance, this tool was built for you. The ADAP Eligibility Calculator provides quick, educational guidance about possible eligibility. Learn more: https://t.co/b9NdIcgzpq

[Partnership for Safe Medicines @SafeMedicines]

FDA enforcement action against Pure Indulgence Aesthetics underscores the role of the Drug Supply Chain Security Act in detecting suspicious drug handling, after inspectors found major inconsistencies in Botox documentation and labeling.

Read more: https://t.co/L7AxCDDuIN.

[Partnership for Safe Medicines @SafeMedicines]

A former ER physician is facing probation and lawsuits after distributing imported tirzepatide to colleagues without medical evaluation.

Read more: https://t.co/fMPHkrejoS.

#PatientSafety #WeightLoss #Healthcare

[Partnership for Safe Medicines @SafeMedicines]

A patient was fighting cancer when severe side effects led to a shocking discovery: the medication he received was counterfeit. His case sparked an international investigation into fake medicines in Mexico’s health care system.

Learn more: https://t.co/pOY4r8O6cl

[Partnership for Safe Medicines @SafeMedicines]

A new price cap for Jardiance has been approved by Maryland's PDAB. The decision raises questions about access and whether state-level pricing systems can adapt to market changes.

Learn more: https://t.co/L7AxCDDuIN.

#DrugsAffordability #Healthcare #PDAB

[Partnership for Safe Medicines @SafeMedicines]

Two arrests have been made after Indian officials seized a large batch of counterfeit Mounjaro injections. The manufacturer, Eli Lilly, is cooperating with authorities as the investigation continues.

Read more: https://t.co/L7AxCDDuIN.

#Mounjaro #DrugSafety #PublicHealth